The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Bicalutamide 50 mg Film-coated Tablets



Lexon Pharmaceuticals (Ireland) LimitedPPA23176/038/001

Main Information

Trade NameBicalutamide 50 mg Film-coated Tablets
Active SubstancesBicalutamide
Dosage FormFilm-coated tablet
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/038/001

Group Information

ATC CodeL02BB Anti-androgens
L02BB03 bicalutamide

Status

License statusAuthorised
Licence Issued06/11/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back